Corrigendum: Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2023-04, Vol.14
Main Authors: Li, Shuqun, Wu, Junyi, Wu, Jiayi, Fu, Yangkai, Zeng, Zhenxin, Li, Yinan, Li, Han, Liao, Weijia, Yan, Maolin
Format: Article
Language:English
Subjects:
anti-PD-1 antibody
immunotherapy
levantinib
nomogram
TACE
unresectable hepatocellular carcinoma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1187423